High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis

Clinical Cancer Research

Volumn 8, Issue 3, 2002, Pages 828-835

  Uzawa, Katsuhiro ^a   Ono, Kanae ^a   Suzuki, Hiroyoshi ^a   Tanaka, Chihaya ^b   Yakushiji, Takashi ^b   Yamamoto, Nobuharu ^b   Yokoe, Hidetaka ^a   Tanzawa, Hideki ^a  

^a CHIBA UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD82 ANTIGEN; CELL PROTEIN; PROTEIN P53; RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENESIS; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METASTASIS; METASTASIS SUPPRESSOR GENE; METHYLATION; MICROSATELLITE INSTABILITY; MOUTH CARCINOMA; PRECANCER; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

AGED; ALLELES; ANTIGENS, CD; AZACITIDINE; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 11; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ENZYME INHIBITORS; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KANGAI-1 PROTEIN; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036304566     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. A global view of the epidemiology of oral cancer
2. Recent advances in epidemiology of head and neck cancer
3. Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN). I. Carcinogen metabolism, DNA repair and cell cycle control
4. KAI-1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2
5. A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23
6. C33 antigen recognized by monoclonal antibodies inhibitory to human T cell leukemia virus type 1-induced syncytium formation is a member of a new family of transmembrane proteins including CD9, CD37, CD53, and CD63
7. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer
8. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss
9. Loss of KAI1 messenger RNA expression in both high-grade and invasive human bladder cancers
10. KAI1, a putative marker for metastatic potential in human breast cancer
11. Reduced expression of the metastasis suppressor gene KAI1 in advanced colon cancer and its metastases
12. Loss of KAI1 expression in the progression of colorectal cancer
13. KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases
14. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases
15. KAI1/CD82 expression in non-small cell lung carcinoma is a novel, favorable prognostic factor
16. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer
17. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression
18. Correlation of reduction in MRP-1/CD9 and KAI1/CD82 expression with recurrences in breast cancer patients
19. Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer
20. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlated with lymph node metastasis in oesophageal squamous cell carcinoma
21. Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma
22. KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers
23. The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53
24. Histological typing of oral and oropharyngeal tumours
25. Head and neck tumours
26. Mutational state of p16/CDKN2 and VHL genes in squamous-cell carcinoma of the oral cavity
27. Abnormalities of the adenomatous polyposis coli gene in human oral squamous-cell carcinoma
28. Laird a sensitive and quantitative DNA methylation assay
29. Genomic organization of the human KAI1 metastasis-suppressor gene
30. Analysis of the ANA gene as a candidate for the chromosome 21q oral cancer susceptibility locus
31. INK4A gene in oral squamous cell carcinomas
32. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene
33. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells
34. Down-regulation of KAI1 messenger RNA expression is not associated with loss of heterozygosity of the KAI1 gene region in lung adenocarcinoma
35. Cancer epigenetics comes of age
36. Methylation of a CpG island within the promoter region of the KAI1 metastasis suppressor gene is not responsible for down-regulation of KAI1 expression in invasive cancers and cancer cell lines
37. The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer
38. Absence of p53-dependent induction of the metastatic suppressor KAI1 gene after DNA damage
39. Nuclear factor-κB-dependent expression of metastasis suppressor KAI1/CD82 gene in lung cancer cell lines expressing mutant p53
40. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues